THERAPEUTICS DEVELOPMENT NETWORK Trademark

Trademark Overview


On Monday, October 19, 2020, a trademark application was filed for THERAPEUTICS DEVELOPMENT NETWORK with the United States Patent and Trademark Office. The USPTO has given the THERAPEUTICS DEVELOPMENT NETWORK trademark a serial number of 90263220. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, March 19, 2021. This trademark is owned by Cystic Fibrosis Foundation. The THERAPEUTICS DEVELOPMENT NETWORK trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

General Information


Serial Number90263220
Word MarkTHERAPEUTICS DEVELOPMENT NETWORK
Filing DateMonday, October 19, 2020
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, March 19, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE
Attorney NameJody H. Drake
Law Office Location CodeL60
Employee NameMUCHA, JOHN EVAN
CorrespondentJODY H. DRAKE
SUGHRUE MION, PLLC
2000 PENNSYLVANIA AVE., NW, SUITE 900
WASHINGTON, DC 20006

Trademark Statements


Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials
Goods and ServicesProviding independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, December 6, 2020
Primary Code035
First Use Anywhere DateMonday, November 30, 1998
First Use In Commerce DateMonday, November 30, 1998

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 6, 2020
Primary Code042
First Use Anywhere DateMonday, November 30, 1998
First Use In Commerce DateMonday, November 30, 1998

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 6, 2020
Primary Code045
First Use Anywhere DateMonday, November 30, 1998
First Use In Commerce DateMonday, November 30, 1998

Trademark Owner History


Party NameCystic Fibrosis Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address4530 Wisconsin Avenue, NW; 5th Fl.
Washington, DC 20016

Trademark Events


Event DateEvent Description
Friday, March 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 19, 2021NON-FINAL ACTION E-MAILED
Friday, March 19, 2021NON-FINAL ACTION WRITTEN
Thursday, March 18, 2021ASSIGNED TO EXAMINER
Sunday, December 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 22, 2020NEW APPLICATION ENTERED IN TRAM